US Stock MarketDetailed Quotes

DMAC DiaMedica Therapeutics

Watchlist
  • 5.270
  • -0.160-2.95%
Trading Jan 2 09:39 ET
225.35MMarket Cap-9.41P/E (TTM)

About DiaMedica Therapeutics Company

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

Company Profile

SymbolDMAC
Company NameDiaMedica Therapeutics
Listing DateDec 7, 2018
Issue Price4.00
Founded2000
CEOMr. Rick Pauls
MarketNASDAQ
Employees19
Fiscal Year Ends12-31
Address301 Carlson Parkway,Suite 210
CityMinneapolis
ProvinceMinnesota
CountryUnited States of America
Zip Code55305
Phone1-763-496-5454
Websitehttp://www.diamedica.com

Company Executives

  • Name
  • Position
  • Salary
  • Rick Pauls
  • Director, President and Chief Executive Officer
  • 1.22M
  • Lorianne Musuoka
  • Chief Medical Officer
  • --
  • Lorianne Masuoka
  • Chief Medical Officer
  • --
  • Scott Kellen
  • Chief Financial Officer, Principal Accounting Officer and Secretary
  • 632.22K
  • David J. Wambeke
  • Chief Business Officer
  • --
  • Dominic R. Cundari
  • Chief Commercial Officer
  • --
  • Julie VanOrsdel Daves
  • Senior Vice President, Clinical Development Operations
  • 533.37K
  • Rebekah de Vitry Fries
  • Vice President of Clinical Operations
  • --
  • Richard D. Pilnik
  • Chairman of the Board
  • 133.98K
  • Dr. Michael Giuffre, M.D.
  • Independent Director
  • 90.93K
  • Tanya Lewis, M.S.
  • Independent Director
  • 91.85K
  • Charles Semba, M.D.
  • Independent Director
  • 89.68K
  • Dr. Richard E. Kuntz, M.D.,M.Sc.
  • Independent Director
  • 96.02K
  • James T. Parsons
  • Independent Director
  • 97.18K
Heat List
US
Overall
Symbol
Price
% Chg

No Data